HCA Healthcare (NYSE:HCA) Releases Quarterly Earnings Results, Beats Expectations By $0.19 EPS

HCA Healthcare (NYSE:HCA) released its quarterly earnings data on Friday. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19, RTT News reports. HCA Healthcare had a net margin of 8.52% and a return on equity of 520.98%. During the same period in the prior year, the firm posted $5.90 earnings per share. HCA Healthcare updated its FY 2025 guidance to 24.050-25.850 EPS.

HCA Healthcare Stock Down 4.0 %

HCA opened at $312.51 on Friday. The business’s 50-day moving average price is $314.10 and its 200-day moving average price is $352.64. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare has a 12 month low of $279.93 and a 12 month high of $417.14. The company has a market cap of $79.16 billion, a P/E ratio of 14.03, a P/E/G ratio of 1.09 and a beta of 1.64.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Barclays cut their price objective on shares of HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating for the company in a research report on Friday, November 8th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Finally, Morgan Stanley decreased their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $385.27.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.